These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 11519219)

  • 1. Combined intralesional interferon alpha 2B and oral vitamin E in the treatment of Peyronie's disease.
    Novak TE; Bryan W; Templeton L; Sikka S; Hellstrom WJ
    J La State Med Soc; 2001 Jul; 153(7):358-63. PubMed ID: 11519219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of intralesional interferon-alpha 2b combined with oral vitamin E for treatment of early stage Peyronie's disease: a randomized and prospective study.
    Inal T; Tokatli Z; Akand M; Ozdiler E; Yaman O
    Urology; 2006 May; 67(5):1038-42. PubMed ID: 16581113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study demonstrating clinical benefit from intralesional interferon alpha 2B in the treatment of Peyronie's disease.
    Ahuja S; Bivalacqua TJ; Case J; Vincent M; Sikka SC; Hellstrom WJ
    J Androl; 1999; 20(4):444-8. PubMed ID: 10452584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of intralesional interferon alpha-2b injection therapy on penile hemodynamics in men with Peyronie's disease.
    Kendirci M; Usta MF; Matern RV; Nowfar S; Sikka SC; Hellstrom WJ
    J Sex Med; 2005 Sep; 2(5):709-15. PubMed ID: 16422829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intralesional interferon-alpha-2B injections for the treatment of Peyronie's disease.
    Dang G; Matern R; Bivalacqua TJ; Sikka S; Hellstrom WJ
    South Med J; 2004 Jan; 97(1):42-6. PubMed ID: 14746421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralesional Injection of Interferon-α2b Improves Penile Curvature in Men with Peyronie's Disease Independent of Plaque Location.
    Stewart CA; Yafi FA; Knoedler M; Mandava SH; McCaslin IR; Sangkum P; Sikka S; Trost L; Hellstrom WJ
    J Urol; 2015 Dec; 194(6):1704-7. PubMed ID: 26144333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease.
    Hellstrom WJ; Kendirci M; Matern R; Cockerham Y; Myers L; Sikka SC; Venable D; Honig S; McCullough A; Hakim LS; Nehra A; Templeton LE; Pryor JL
    J Urol; 2006 Jul; 176(1):394-8. PubMed ID: 16753449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and tolerability of local treatment with iloprost, a prostacyclin analogue, in patients with Peyronie's disease: a phase I study.
    Pavone C; Napoli G; Caruana G; Alonge V; Usala M; Abbadessa D
    BJU Int; 2012 Jul; 110(1):117-21. PubMed ID: 22176734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological Management of Peyronie's Disease.
    Trost LW; Gur S; Hellstrom WJ
    Drugs; 2007; 67(4):527-45. PubMed ID: 17352513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intralesional interferon-alpha-2b for the treatment of Peyronie's disease.
    Lacy GL; Adams DM; Hellstrom WJ
    Int J Impot Res; 2002 Oct; 14(5):336-9. PubMed ID: 12454683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study.
    Rehman J; Benet A; Melman A
    Urology; 1998 Apr; 51(4):620-6. PubMed ID: 9586617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intralesional interferon in the treatment of Peyronie's disease: a pilot study.
    Judge IS; Wisniewski ZS
    Br J Urol; 1997 Jan; 79(1):40-2. PubMed ID: 9043494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Peyronie's disease with local interferon-alpha 2b.
    Wegner HE; Andresen R; Knipsel HH; Miller K
    Eur Urol; 1995; 28(3):236-40. PubMed ID: 8536778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Peyronie's disease with local interferon-alpha 2b.
    Brake M; Loertzer H; Horsch R; Keller H
    BJU Int; 2001 May; 87(7):654-7. PubMed ID: 11350406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of intralesional clostridial collagenase injection therapy for Peyronie's disease: a prospective, single-center, non-placebo-controlled study.
    Jordan GH
    J Sex Med; 2008 Jan; 5(1):180-7. PubMed ID: 18173766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of penile hemodynamic status and adjustment of treatment alternatives in Peyronie's disease.
    Erdogru T; Savas M; Yilmaz N; Faruk Usta M; Koksal T; Ates M; Baykara M
    Asian J Androl; 2002 Sep; 4(3):187-90. PubMed ID: 12364974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical management of Peyronie's disease.
    Hellstrom WJ
    J Androl; 2009; 30(4):397-405. PubMed ID: 18974422
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of Peyronie's disease with intralesional verapamil injection.
    Levine LA
    J Urol; 1997 Oct; 158(4):1395-9. PubMed ID: 9302129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of loss of penile rigidity associated with Peyronie's disease.
    Krane RJ
    Scand J Urol Nephrol Suppl; 1996; 179():147-50. PubMed ID: 8908682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of intralesional injection of hyaluronic acid compared with verapamil in Peyronie's disease: preliminary results from a prospective, double-blinded, randomized study.
    Favilla V; Russo GI; Zucchi A; Siracusa G; Privitera S; Cimino S; Madonia M; Cai T; Cavallini G; Liguori G; D'Achille G; Silvani M; Franco G; Verze P; Palmieri A; Torrisi B; Mirone V; Morgia G
    Andrology; 2017 Jul; 5(4):771-775. PubMed ID: 28718527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.